ResearcherInstitute of Basic Medical Sciences of the Chinese Academy of Medical SciencesNo recent work listed

Xiechuan Weng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2601-4227; OpenAlex author ID A5033520032. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper

Papers 3

Landmarks in pancreatic cancer studies. Last author DOI 10.1186/s12935-022-02803-8 ↗
Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.695645 ↗
Metastatic pancreatic cancer: Mechanisms and detection (Review). Co-author DOI 10.3892/or.2021.8182 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fan Xu · 3 shared papers, 2021–2022 · strength 0.48
Jie Chen · 2 shared papers, 2021–2022 · strength 0.31
- Paper Landmarks in pancreatic cancer studies. DOI 10.1186/s12935-022-02803-8 ↗
- Paper Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. DOI 10.3389/fonc.2021.695645 ↗
Xiangling Chen · 1 shared paper, 2021 · strength 0.17
- Paper Metastatic pancreatic cancer: Mechanisms and detection (Review). DOI 10.3892/or.2021.8182 ↗
Liqiong Yang · 1 shared paper, 2021 · strength 0.15
- Paper Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. DOI 10.3389/fonc.2021.695645 ↗
Qing Li · 1 shared paper, 2021 · strength 0.15
- Paper Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. DOI 10.3389/fonc.2021.695645 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.